Funds0 funds · $0
Top YTD · 0 of 0YTD
Compare tray · 2
CANCVOO
Compare 2 funds →
Your desk · 0 saved viewsOpen
Save view, at the bottom, keeps this one here
0 fundsShow all 0

CANC Payouts by Year

3Y
Latest payout, Dec 2025
$0.02
a share · once a year
0.0% yield
3 years added up
$0.90 a share
$0.15’23$0.73’24$0.02’25
Tema CANC · per-share distributions by ex-date · 2023–2025
@TheETFTracker·theetftracker.com

Cards for This View

CANC’s Top 10 Holdings

Today
45.4%of CANC sits in these 10
1GMABGenmab A/s5.96%
2RVMDRevolution Medicines5.38%
3LLYEli Lilly &5.27%
4MRKMerck &4.89%
5COGTCogent Biosciences4.54%
6NOVN.SNovartis Ag4.12%
7ABBVAbbvie3.95%
8EXELExelixis3.77%
9ONCBeone Medicines3.76%
10HALOHalozyme Therapeutics3.75%
Tema CANC · weight in the fund · as of Nov 5, 2026
@TheETFTracker·theetftracker.com

CANC vs Peer Average

YTD
CANCAvsBPeer average
1D−4.9%[…]
1M+0.4%[…]
3M−4.7%[…]
YTD+17.5%[…]
1Y+34.1%[…]
3Y+91.6%[…]
0–0level
0 peers · each row scaled to its leader
@TheETFTracker·theetftracker.com